USX:NGENF - NervGen Pharma Corp NervGen Pharma Corp
Sector: Health Care, Industry: Biotechnology
Next Earnings: 29 Mar 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 1.59    +0.07 (+4.61%)

27 Mar 2024


Loading...
Loading...
Loading...

General

CEO: Mr. William Joseph Radvak BASc

Headquarters: US

Employees: 0

Homepage

Description

NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server J

About · FAQs · StocksCafe © 2024 · Privacy · Terms